Insider Trading July 6, 2026 05:09 PM

Xometry Director Altschuler Offloads Over $533K in Shares Amid Platform Expansion

Insider sale coincides with company's $225M capital raise and injection molding platform upgrades, raising questions about valuation and market positioning.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
XMTR

Xometry Inc. (NASDAQ: XMTR) director Randolph Altschuler executed an automatic sale of 5,722 Class A Common Stock shares on July 2, 2026, totaling $533,869. The transaction, processed under a pre-established Rule 10b5-1 plan, was primarily intended to satisfy tax withholding requirements linked to restricted stock unit vesting. Following the sale, Altschuler retains direct ownership of 428,750 Class A shares and 1,475,311 Class B shares, alongside substantial indirect holdings through family trusts and his spouse. The insider activity occurs as Xometry advances its manufacturing capabilities and raises capital through a public offering.

Xometry Director Altschuler Offloads Over $533K in Shares Amid Platform Expansion
XMTR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Xometry director Randolph Altschuler sold 5,722 shares for $533,869 to cover tax withholding obligations on vested restricted stock units.
  • Xometry raised $225 million through a public stock offering at $85 per share, with underwriters holding a 30-day option for additional shares.
  • The company expanded its injection molding platform with new materials, expert consultations, and automated routing intelligence.

Randolph Altschuler, serving as a director at Xometry Inc. (NASDAQ: XMTR), completed a sale of 5,722 shares of the company's Class A Common Stock on July 2, 2026. The transaction resulted in proceeds totaling $533,869. These sales were processed automatically under a Rule 10b5-1 trading plan, which Altschuler established at least 90 days before the execution date. The primary purpose of these sales was to cover tax withholding obligations associated with the vesting of restricted stock units.

The shares were divested across multiple transactions, with execution prices ranging from $90.46 to $97.205 per share. As of the report, XMTR shares trade at $94.27, placing the stock near its 52-week high of $99.86. This valuation reflects a 166% gain over the preceding year. Market analysis indicates that the stock may be overvalued relative to its calculated Fair Value. For investors requiring detailed valuation metrics, comprehensive research reports are available through InvestingPro, which covers over 1,400 US equities with expert analysis and actionable intelligence.

Following the transaction, Altschuler's direct holdings include 428,750 shares of Class A Common Stock and 1,475,311 shares of Class B Common Stock. Indirect ownership remains significant through various trusts and his spouse. His spouse holds 561,270 Class A shares. The 2021 Tigers Trust holds 85,582 shares. The Altschuler Family Trust (2020) holds 455,248 shares. The Matthew Sladkin Altschuler 2012 Trust holds 324,533 shares. The Noah Sladkin Altschuler 2012 Trust holds 324,533 shares. The Sasha Sladkin Altschuler 2012 Trust holds 324,533 shares.

In concurrent developments, Xometry announced a $225 million public stock offering. Shares were priced at $85 each, with the company offering 2,647,059 shares of Class A common stock. Underwriters received a 30-day option to purchase up to an additional 397,058 shares at the same price. The company also expanded its injection molding platform, adding glass-filled Nylon, PBT, PC-PBT, PLA, PPE-PS, and PSU to its materials catalog. New features include on-demand expert consultations and simplified reordering processes. The platform's process-recommendation intelligence now automatically routes mold-suited parts to injection molding, supporting ongoing manufacturing capability enhancements.

Risks

  • Market valuation concerns exist as XMTR trades near its 52-week high with a 166% annual gain, suggesting potential overvaluation relative to Fair Value.
  • Capital dilution risk is present due to the $225 million public offering and potential exercise of the underwriters' option for additional shares.
  • Platform integration complexity may arise from rapid expansion of materials catalog and automated routing features within the injection molding division.

More from Insider Trading

Gemini Space Station Interim CFO Disposes of RSU-Related Shares Amidst Strategic Diversification Jul 6, 2026 Indie Semiconductor CFO Wu Naixi Sells $85,913 in Class A Shares Jul 6, 2026 Indie Semiconductor COO Michael Wittmann Offloads Shares to Cover Tax Obligations Jul 6, 2026 Clover Health CEO Reynoso Executes Tax-Related Sale of $32,764 in Shares Jul 6, 2026 Etsy Director Frederick R. Wilson Executes $1.48M Stock Sale Under Pre-Arranged Plan Jul 6, 2026